retatrutide benefits besides weight loss How works: mechanism of action and onset explained Retatrutide UK 2026: Phase 3

Its action on GIP receptors enhances insulin release to help manage blood sugar levels

Lewis EJ, Hunsicker LG, Bain RP, Rohde RD

The bac water ratio for retatrutide is not set in stone

Zepbound is indicated for chronic weight management (FDA approved November 2023)

GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution By Donnisa Edmonds, C2ST Intern, University of Chicago In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as a treatment for chronic weight management

Any changes to the frequency of your GLP-1 medications should be made in consultation with your healthcare provider